OpenLB
Open Library of Bioscience
Advanced Search
Mediators of inflammation
2013;2013 916497.

Cytokines and chemokines in irritant contact dermatitis.

Haur Yueh Lee, Marco Stieger, Nikhil Yawalkar, Masato Kakeda
Author Information
  1. Haur Yueh Lee: Department of Dermatology, Inselspital, University of Bern, 3010 Bern, Switzerland.
  2. Marco Stieger: Department of Dermatology, Inselspital, University of Bern, 3010 Bern, Switzerland.
  3. Nikhil Yawalkar: Department of Dermatology, Inselspital, University of Bern, 3010 Bern, Switzerland.
  4. Masato Kakeda: Department of Dermatology, Inselspital, University of Bern, 3010 Bern, Switzerland ; Department of Dermatology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
PMID: 24371376 DOI: 10.1155/2013/916497

Abstract

Irritant contact dermatitis is a result of activated innate immune response to various external stimuli and consists of complex interplay which involves skin barrier disruption, cellular changes, and release of proinflammatory mediators. In this review, we will focus on key cytokines and chemokines involved in the pathogenesis of irritant contact dermatitis and also contrast the differences between allergic contact dermatitis and irritant contact dermatitis.

References

  1. J Invest Dermatol. 1996 Mar;106(3):397-403 [PMID: 8648167]
  2. Contact Dermatitis. 2009 Jan;60(1):2-20 [PMID: 19125717]
  3. J Appl Toxicol. 2000 Jul-Aug;20(4):335-41 [PMID: 10942909]
  4. J Invest Dermatol. 2000 Aug;115(2):292-8 [PMID: 10951249]
  5. Eur J Immunol. 1997 Nov;27(11):3031-8 [PMID: 9394834]
  6. Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):374-81 [PMID: 17873575]
  7. Int Immunol. 2001 Jan;13(1):95-103 [PMID: 11133838]
  8. Contact Dermatitis. 1995 Oct;33(4):258-66 [PMID: 8654078]
  9. Allergol Int. 2010 Dec;59(4):389-97 [PMID: 20864798]
  10. J Dermatol Sci. 2010 Mar;57(3):216-8 [PMID: 20138475]
  11. J Invest Dermatol. 1990 Dec;95(6 Suppl):105S-107S [PMID: 2258625]
  12. Br J Dermatol. 1995 Mar;132(3):345-52 [PMID: 7536438]
  13. J Clin Invest. 1991 Mar;87(3):1066-71 [PMID: 1999487]
  14. Skin Pharmacol Physiol. 2008;21(3):124-35 [PMID: 18523410]
  15. Lancet. 1991 Jan 26;337(8735):211-4 [PMID: 1670850]
  16. J Investig Dermatol Symp Proc. 1998 Aug;3(2):121-7 [PMID: 9734825]
  17. J Immunol. 1997 Dec 15;159(12):6203-8 [PMID: 9550423]
  18. J Invest Dermatol. 1993 Sep;101(3):310-5 [PMID: 8370967]
  19. J Immunol. 2010 May 1;184(9):4880-8 [PMID: 20357258]
  20. Contact Dermatitis. 2010 Dec;63(6):320-32 [PMID: 20731689]
  21. J Invest Dermatol. 2002 Nov;119(5):1128-36 [PMID: 12445203]
  22. J Invest Dermatol. 2011 Feb;131(2):418-25 [PMID: 21068755]
  23. Skin Pharmacol. 1995;8(1-2):49-59 [PMID: 7786525]
  24. J Exp Med. 1991 Mar 1;173(3):673-9 [PMID: 1900080]
  25. J Invest Dermatol. 2006 Aug;126(8):1813-22 [PMID: 16645592]
  26. BMC Immunol. 2004 Apr 26;5:7 [PMID: 15109401]
  27. Br J Dermatol. 2013 Feb;168(2):326-332 [PMID: 23039796]
  28. Eur J Immunol. 1994 Sep;24(9):2254-7 [PMID: 8088339]
  29. J Eur Acad Dermatol Venereol. 2013 Aug;27(8):1040-3 [PMID: 22364598]
  30. Eur J Immunol. 2010 Jul;40(7):2026-34 [PMID: 20432237]
  31. Br J Dermatol. 1997 Oct;137(4):540-4 [PMID: 9390328]
  32. J Exp Med. 1995 Jul 1;182(1):99-108 [PMID: 7790826]
  33. Clin Exp Dermatol. 2002 Mar;27(2):138-46 [PMID: 11952708]
  34. J Allergy Clin Immunol. 2012 Apr;129(4):1031-9.e1 [PMID: 22322004]
  35. Eur J Immunol. 2008 Nov;38(11):2975-80 [PMID: 18991275]
  36. Contact Dermatitis. 1996 Dec;35(6):355-60 [PMID: 9118630]
  37. Contact Dermatitis. 2000 Mar;42(3):123-7 [PMID: 10727161]
  38. Microsc Res Tech. 1997 May 1;37(3):193-9 [PMID: 9144631]
  39. J Allergy Clin Immunol. 2006 Jul;118(1):3-21; quiz 22-3 [PMID: 16815133]
  40. Lymphokine Cytokine Res. 1994 Dec;13(6):367-75 [PMID: 7703310]
  41. J Immunol. 1999 Jan 1;162(1):186-94 [PMID: 9886385]
  42. J Invest Dermatol. 2007 Jul;127(7):1574-6 [PMID: 17568800]
  43. Physiol Rev. 1990 Apr;70(2):427-51 [PMID: 1690903]
  44. Int Arch Occup Environ Health. 2003 Jun;76(5):339-46 [PMID: 12827369]
  45. Br J Dermatol. 2009 Dec;161(6):1301-6 [PMID: 19785613]
  46. Toxicol In Vitro. 2006 Feb;20(1):117-24 [PMID: 16099135]
  47. Australas J Dermatol. 2008 Feb;49(1):1-9; quiz 10-1 [PMID: 18186838]
  48. Int Immunol. 1995 Mar;7(3):343-52 [PMID: 7794816]
  49. J Immunotoxicol. 2013 Apr-Jun;10(2):192-200 [PMID: 22966985]
  50. Skin Pharmacol Physiol. 2009;22(2):103-13 [PMID: 19188758]
  51. Exp Dermatol. 2005 Feb;14(2):109-16 [PMID: 15679580]
  52. J Allergy Clin Immunol. 2007 Jun;119(6):1470-80 [PMID: 17337293]
  53. J Invest Dermatol. 1997 Jun;108(6):892-6 [PMID: 9182817]
  54. Exp Dermatol. 2007 Dec;16(12):1032-40 [PMID: 18031463]
  55. Arch Dermatol Res. 1990;282(4):238-45 [PMID: 2115318]
  56. Contact Dermatitis. 2012 Apr;66(4):221-7 [PMID: 22404198]
  57. J Invest Dermatol. 2000 Aug;115(2):168-76 [PMID: 10951232]

MeSH Term

Animals
Chemokines
Cytokines
Dendritic Cells
Dermatitis, Irritant
Endothelial Cells
Fibroblasts
Humans
Keratinocytes
Lymphocytes

Chemicals

Chemokines
Cytokines
Journal Article Review

Word Cloud

Created with Highcharts 10.0.0contactdermatitisirritantchemokinesIrritantresultactivatedinnateimmuneresponsevariousexternalstimuliconsistscomplexinterplayinvolvesskinbarrierdisruptioncellularchangesreleaseproinflammatorymediatorsreviewwillfocuskeycytokinesinvolvedpathogenesisalsocontrastdifferencesallergicCytokines

Similar Articles

Cited By